Track 7 : Patient organizations and their role in drug development or clinical research

Rare disease drug development could benefit substantially from increased patient engagement and input to enhance understanding of the key aspects of disease impact, ways to measure these impacts and patients' perspectives on the benefit-risk profile of potential therapies.

 

    Track 7 : Patient organizations and their role in drug development or clinical research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in